- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 31/277 - NitrilesIsonitriles ayant un cycle, p. ex. vérapamil
Détention brevets de la classe A61K 31/277
Brevets de cette classe: 1505
Historique des publications depuis 10 ans
|
126
|
116
|
129
|
111
|
97
|
129
|
99
|
105
|
105
|
94
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 20230 |
34 |
| University of Tennessee Research Foundation | 754 |
27 |
| Vanda Pharmaceuticals, Inc. | 369 |
19 |
| Pitney Pharmaceuticals Pty Limited | 19 |
17 |
| Milestone Pharmaceuticals Inc. | 23 |
16 |
| NeuroDerm, Ltd. | 139 |
15 |
| Orion Corporation | 693 |
15 |
| Arvinas Operations, Inc. | 242 |
15 |
| The Trustees of Columbia University in the City of New York | 3595 |
14 |
| Nikang Therapeutics, Inc. | 105 |
14 |
| Bristol-myers Squibb Company | 4848 |
13 |
| Massachusetts Eye and Ear Infirmary | 386 |
12 |
| Ono Pharmaceutical Co., Ltd. | 427 |
11 |
| National Institute of Biological Sciences, Beijing | 100 |
10 |
| Bayer Pharma AG | 1048 |
9 |
| Duke University | 3103 |
9 |
| Intrance Medical Systems Inc. | 13 |
9 |
| The General Hospital Corporation | 4792 |
8 |
| The George Institute for Global Health | 29 |
8 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3367 |
8 |
| Autres propriétaires | 1222 |